Strategic fit ViS Research, now part of IQVIA, sits at the intersection of IT services and clinical research optimization, presenting a joint opportunity to cross-sell data-driven feasibility platforms and global research infrastructure analytics to IQVIA’s enterprise client base.

Cost efficiency The platform emphasizes rapid, cost-efficient trial planning by reducing feasibility time and questionnaire overhead, offering a strong value proposition for sponsors and CROs seeking faster study startup and lower upfront costs.

Global reach Access to a global map of clinical research infrastructure and site/investigator engagement capabilities aligns with multinational trials, suggesting upsell potential to expand coverage, language localization, and country-specific feasibility analytics.

Center engagement Online profiles for research centers that answer majority of feasibility questions create potential for deeper collaboration, data licensing, and enhanced sponsor-site matching services for faster enrollment and better site performance metrics.

Growth signals Revenue range indicates a scalable platform with room to expand into larger deals, more services within IQVIA’s portfolio, and opportunities to bundle feasibility analytics with broader real-world evidence, analytics, and trial planning solutions.